Improving the Safety of Oral Chemotherapy at an Academic Medical Center [Quality in Action]

Conclusion:
OC poses many of the same risks as intravenous chemotherapy and should be prescribed and reviewed with the same oversight. At our institution, involvement of an oncology-trained pharmacist in the review of OC led to meaningful interventions in one third of the orders.

Source: Journal of Oncology Practice - January 12, 2016 Category: Cancer & Oncology Authors: Shah, N. N., Casella, E., Capozzi, D., McGettigan, S., Gangadhar, T. C., Schuchter, L., Myers, J. S. Tags: Patient safety, Quality of care Quality in Action Source Type: research